Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Non-Current Assets (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Other Non-Current Assets readings, the most recent being $47000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 95.85% to $47000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $47000.0, a 95.85% decrease, with the full-year FY2025 number at $47000.0, down 95.85% from a year prior.
  • Other Non-Current Assets hit $47000.0 in Q4 2025 for Lucid Diagnostics, down from $52000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.7 million in Q3 2023 to a low of $47000.0 in Q4 2025.
  • Median Other Non-Current Assets over the past 5 years was $1.1 million (2023), compared with a mean of $1.1 million.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 152.78% in 2023 and later crashed 95.85% in 2025.
  • Lucid Diagnostics' Other Non-Current Assets stood at $1.1 million in 2021, then rose by 19.27% to $1.3 million in 2022, then fell by 14.95% to $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024, then crashed by 95.85% to $47000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $47000.0 (Q4 2025), $52000.0 (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.